{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:05:25Z","timestamp":1791309925467,"version":"4.3.1"},"reference-count":55,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the immediate postpartum period. A low platelet count is often an incidental feature, but it might also provide a biomarker of a coexisting systemic or gestational disorder and a potential reason for a maternal intervention or treatment that might pose harm to the fetus. This chapter reflects our approach to these issues with an emphasis on advances made over the past 5 to 10 years in understanding and managing the more common causes of thrombocytopenia in pregnancy. Recent trends in the management of immune thrombocytopenia translate into more women contemplating pregnancy while on treatment with thrombopoietin receptor agonists, rituximab, or mycophenylate, which pose known or unknown risks to the fetus. New criteria to diagnose preeclampsia, judicious reliance on measurement of ADAMTS13 to make management decisions in suspected thrombotic thrombocytopenic purpura, new evidence supporting the efficacy and safety of anticomplement therapy for atypical hemolytic uremic syndrome during pregnancy, and implications of thrombotic microangiopathies for subsequent pregnancies are evolving rapidly. The goals of the chapter are to help the hematology consultant work through the differential diagnosis of thrombocytopenia in pregnancy based on trimester of presentation, severity of thrombocytopenia, and coincident clinical and laboratory manifestations, and to provide guidance for dealing with some of the more common and difficult diagnostic and management decisions.<\/jats:p>","DOI":"10.1182\/asheducation-2017.1.144","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T18:13:11Z","timestamp":1555438391000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":51,"title":["Thrombocytopenia in pregnancy"],"prefix":"10.1182","volume":"2017","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-504X","authenticated-orcid":false,"given":"Douglas B.","family":"Cines","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine,"},{"name":"Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6811-7980","authenticated-orcid":false,"given":"Lisa D.","family":"Levine","sequence":"additional","affiliation":[{"name":"Maternal and Child Health Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111706185172000_B1","doi-asserted-by":"crossref","DOI":"10.1182\/asheducation-2010.1.397","article-title":"Thrombocytopenia in pregnancy","volume-title":"Hematology Am Soc Hematol Educ Program","author":"McCrae","year":"2010"},{"issue":"1","key":"2019111706185172000_B2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2012-08-448944","article-title":"How I treat thrombocytopenia in pregnancy","volume":"121","author":"Gernsheimer","year":"2013","journal-title":"Blood"},{"key":"2019111706185172000_B3","article-title":"Clinical Practice Guide on Thrombocytopenia in Pregnancy","author":"Rajasekhar","year":"2013"},{"issue":"3","key":"2019111706185172000_B4","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/AOG.0000000000001641","article-title":"Practice bulletin no. 166: thrombocytopenia in pregnancy","volume":"128","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2019111706185172000_B5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"2019111706185172000_B6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-08-551960","article-title":"How I treat type 2 variant forms of von Willebrand disease","volume":"125","author":"Tosetto","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111706185172000_B7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/14767058.2015.1018169","article-title":"Clinical features and outcome of pregnancy with SLE-associated thrombocytopenia","volume":"29","author":"Xu","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"2019111706185172000_B8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0036-1592336","article-title":"Pregnancy and antiphospholipid syndrome","volume":"42","author":"Schreiber","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2019111706185172000_B9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0002-9378(90)90996-K","article-title":"Thrombocytopenia at delivery: a prospective survey of 6715 deliveries","volume":"162","author":"Burrows","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019111706185172000_B10","first-page":"29","article-title":"Platelet count at term pregnancy: a reappraisal of the threshold","volume":"95","author":"Boehlen","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2019111706185172000_B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.360","article-title":"Causes of thrombocytopenia in triplet gestations","volume":"189","author":"Al-Kouatly","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019111706185172000_B12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-2002-36693","article-title":"Gestational thrombocytopenia and pregnancy-induced antithrombin deficiency: progenitors to the development of the HELLP syndrome and acute fatty liver of pregnancy","volume":"28","author":"Minakami","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2019111706185172000_B13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10245330400020421","article-title":"Severe gestational (incidental) thrombocytopenia: to treat or not to treat","volume":"10","author":"Win","year":"2005","journal-title":"Hematology"},{"issue":"13","key":"2019111706185172000_B14","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111706185172000_B15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02982137","article-title":"Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"issue":"6","key":"2019111706185172000_B16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bjh.12976","article-title":"Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women","volume":"166","author":"Loustau","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111706185172000_B17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2141.2009.07899.x","article-title":"The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals","volume":"148","author":"van Veen","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111706185172000_B18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2141.2003.04567.x","article-title":"Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy","volume":"123","author":"Michel","year":"2003","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111706185172000_B19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"issue":"21","key":"2019111706185172000_B20","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.5005.5005","article-title":"Recombinant human thrombopoietin: a novel therapeutic option for patients with immune thrombocytopenia in pregnancy [abstract]","volume":"124","author":"Kong","year":"2014","journal-title":"Blood"},{"issue":"2 Pt 2","key":"2019111706185172000_B21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/AOG.0b013e31828d5b56","article-title":"Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy","volume":"122","author":"Patil","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 2 suppl 1","key":"2019111706185172000_B22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000000371","article-title":"Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy","volume":"124","author":"Decroocq","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2019111706185172000_B23","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111706185172000_B24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.14045","article-title":"How we manage thrombotic microangiopathies in pregnancy","volume":"173","author":"Thomas","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111706185172000_B25","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2019111706185172000_B26","doi-asserted-by":"crossref","first-page":"e0142538","DOI":"10.1371\/journal.pone.0142538","article-title":"Syncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet function","volume":"10","author":"Tannetta","year":"2015","journal-title":"PLoS One"},{"issue":"17","key":"2019111706185172000_B27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2016-03-705434","article-title":"Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts","volume":"128","author":"Kohli","year":"2016","journal-title":"Blood"},{"key":"2019111706185172000_B28","article-title":"Creasy and Resnick\u2019s Maternal-Fetal Medicine: Principle and Practice","author":"Creasy","year":"2009","edition":"6th ed"},{"key":"2019111706185172000_B29","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.12659\/MSM.895220","article-title":"Corticosteroid therapy for management of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome: a meta-analysis","volume":"21","author":"Mao","year":"2015","journal-title":"Med Sci Monit"},{"issue":"5","key":"2019111706185172000_B30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"issue":"2","key":"2019111706185172000_B31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"issue":"5 Pt 1","key":"2019111706185172000_B32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2019111706185172000_B33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"2019111706185172000_B34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2008-1040563","article-title":"Acute fatty liver of pregnancy","volume":"7","author":"Riely","year":"1987","journal-title":"Semin Liver Dis"},{"issue":"24","key":"2019111706185172000_B35","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111706185172000_B36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0036-1587683","article-title":"Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome microangiopathy in pregnancy","volume":"42","author":"Scully","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2019111706185172000_B37","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"issue":"4","key":"2019111706185172000_B38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jca.10005","article-title":"Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy","volume":"16","author":"McMinn","year":"2001","journal-title":"J Clin Apher"},{"issue":"2","key":"2019111706185172000_B39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111706185172000_B40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1537-2995.2004.03422.x","article-title":"Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"44","author":"Vesely","year":"2004","journal-title":"Transfusion"},{"issue":"2","key":"2019111706185172000_B41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2008.03.011","article-title":"Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006","volume":"199","author":"Martin","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2019111706185172000_B42","doi-asserted-by":"crossref","DOI":"10.1182\/asheducation-2015.1.644","article-title":"Syndromes of thrombotic microangiopathy associated with pregnancy","volume-title":"Hematology Am Soc Hematol Educ Program","author":"George","year":"2015"},{"issue":"11","key":"2019111706185172000_B43","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","article-title":"Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura","volume":"123","author":"Jiang","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111706185172000_B44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019111706185172000_B45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","article-title":"Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura","volume":"17","author":"Scully","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"2019111706185172000_B46","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2013070796","article-title":"Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?","volume":"25","author":"Marinozzi","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2019111706185172000_B47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111706185172000_B48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy-related thrombotic microangiopathies: clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus Apheresis Sci"},{"issue":"11","key":"2019111706185172000_B49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111706185172000_B50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.transci.2014.08.027","article-title":"Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome","volume":"51","author":"Mussoni","year":"2014","journal-title":"Transfus Apheresis Sci"},{"issue":"12","key":"2019111706185172000_B51","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2019111706185172000_B52","doi-asserted-by":"crossref","first-page":"e2891","DOI":"10.1097\/MD.0000000000002891","article-title":"Characterization of patients with lupus nephritis included in a large cohort from the Spanish Society of Rheumatology registry of patients with systemic lupus erythematosus (RELESSER)","volume":"95","author":"Galindo-Izquierdo","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2019111706185172000_B53","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00296-017-3686-5","article-title":"Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence","volume":"37","author":"Sciascia","year":"2017","journal-title":"Rheumatol Int"},{"issue":"2","key":"2019111706185172000_B54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama","year":"2009","journal-title":"Thromb Haemost"},{"issue":"13","key":"2019111706185172000_B55","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1177\/0961203310375262","article-title":"Thrombotic microangiopathy and the antiphospholipid syndrome","volume":"19","author":"Johnsen","year":"2010","journal-title":"Lupus"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/144\/1249628\/hem00020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/144\/1249628\/hem00020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T06:19:19Z","timestamp":1573971559000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2017\/1\/144\/21061\/Thrombocytopenia-in-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2017.1.144","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}